<DOC>
	<DOCNO>NCT00429975</DOCNO>
	<brief_summary>The purpose study compare levofloxacin v ceftriaxone impact cytokine production patient pneumococcal pneumonia .</brief_summary>
	<brief_title>Ceftriaxone Vs Levofloxacin Cytokine Expression Pneumococcal Pneumonia</brief_title>
	<detailed_description>Bacterial alveolar invasion follow compartmentalized inflammatory response . Data suggest antimicrobial may induce differential release cytokine , potential either accelerate regulate cytokine production . The aim study compare effect ceftriaxone compare levofloxacin cytokine systemic concentration patient pneumococcal pneumonia .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Pneumococcal</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>patient acute febrile respiratory illness accompany new radiographic infiltrate consistent diagnosis . confirm pneumococcal aetiology age &lt; 18 year , pneumonia distal endobronchial obstruction , pulmonary tuberculosis , bronchiectasis , know allergy Blactams fluoroquinolones , underlie systemic autoimmune disease immunocompromised state include patient maintenance oral corticosteroid , HIV infection , pregnancy , patient receive antimicrobial therapy 15 day precede current episode receive fluoroquinolones last month , non steroidal antiinflammatory therapy last two week . Patients renal failure ( serum creatinine &gt; 2 mg / dL ) , patient document pneumococcal pneumonia previous 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>fluorquinolones ,</keyword>
	<keyword>b-lactams ,</keyword>
	<keyword>immunomodulation .</keyword>
</DOC>